A company presentation will take place during the conference’s Innovation track on Friday, March 28th at 9:00am. NeauxCancer conference’s Innovation track spotlights the most promising emerging ...
The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...
Mining operations at the Tomingley Gold Operations; exploration and evaluation activities on tenements held by the group; and pursuing strategic investments in gold exploration companies.